Similar and divergent features in mammalian and yeast prions

Microbes and Infection

Volumn 4, Issue 4, 2002, Pages 461-469

  Bousset, Luc ^a   Melki, Ronald ^a  

^a LABORATOIRE D ENZYMOLOGIE ET BIOCHIMIE STRUCTURALES   (France)

Author keywords

Amyloid fibrils; Auto assembly; Conformational changes; Molecular chaperones; Nucleation polymerization; Prion; PrP; Saccharomyces cerevisiae; Structural inheritance; Sup35p; Ure2p

Indexed keywords

CHAPERONE; ISOPROTEIN; PRION PROTEIN;

GENETIC VARIABILITY; MAMMAL; MOLECULAR MODEL; NONHUMAN; PHENOTYPE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW; SEQUENCE HOMOLOGY; SPECIES COMPARISON; STRAIN DIFFERENCE; YEAST;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MAMMALS; MOLECULAR CHAPERONES; PRIONS; PROTEIN CONFORMATION; SPECIES SPECIFICITY; YEASTS;

MAMMALIA; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0036215385     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01561-7     Document Type: Review

References (110)

1. Does the agent of scrapie replicate without nucleic acid?
2. Self-replication and scrapie
3. Novel proteinaceous infectious particles cause scrapie
4. Identification of a protein that purifies with scrapie prion
5. Prions proteins isoform, a convergence of biological and structural investigations
6. Transgenic and knockout mice in research on prion diseases
7. Expression of amino-terminally truncated PrP in mouse leading to ataxia and specific cerebellar lesions
8. Signal transduction through prion protein
9. Further purification and characterization of scrapie prions
10. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing
11. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins
12. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy
13. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity
14. Deadly conformations - Protein misfolding in prion disease
15. Prion diseases and the BSE crisis
16. Prions
17. Cell-free formation of protease-resistant prion protein
18. Scrapie prions aggregate to form amyloid-like birefringent rods
19. Separation of scrapie prion infectivity from PrP amyloid polymers
20. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein
21. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity
22. PSI, a cytoplasmic suppressor of super-suppressor in yeast
23. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast
24. Genetic aspects of [URE3] a non-Mendelian cytoplasmically inherited mutation in yeast
25. Etude physiologique d'une mutation permettant l'incorporation d'acide ureidosuccinique chez la levure
26. The Prsi factor of yeast: A problem in inheritance
27. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae
28. Evidence for a prion analog in S. cerevisiae: The [URE3] non-Mendelian genetic element as an altered URE2 protein
29. Reversion analysis of [psi-] mutations in Saccharomyces cerevisiae
30. Genetic mapping of nonsense suppressors in yeast
31. Recessive super-suppressors in yeast
32. Regulation of glutamine-repressible gene products by GLN3 function in Saccharomyces cerevisiae
33. Regulation of nitrogen assimilation in Saccharomyces cerevisiae: Roles of the URE2 and GLN3 genes
34. The URE2 gene product of Saccharomyces cerevisiae plays an important role in the cellular response to the nitrogen source and has homology to glutathione-S-transferases
35. Transmissible and non-transmissible amyloidoses: Autocatalyticv post-translational conversion of host precursor proteins to β-pleated conformations
36. Molecular biology of prion diseases
37. Seeding "one-dimensional-crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
38. Structural clues to prion replication
39. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein
40. Quantifying the kinetic parameters of prion replication
41. Creating a protein-based element of inheritance
42. A yeast prion provides a mechanism for genetic variation and phenotypic diversity
43. Prion protein of 106 residues creates an artificial barrier for prion replication in transgenic mice
44. The dominant PNM2- mutation which eliminates [PSI] factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene
45. The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-mendelian determinant [psi+] in the yeast saccharomyces cerevisiae
46. Oligopeptide-repeat expansions modulate 'prion-only' inheritance in yeast
47. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion
48. Rnq1: An epigenetic modifier of protein function in yeast
49. Molecular basis of yeast prion species barrier
50. Glutamine repeats and neurodegenerative diseases: Molecular aspects
51. NMR structure of the mouse prion protein domain PrP(121-231)
52. Structure of the recombinant full-length hamster prion protein PrP(29-231): The N-terminus is highly flexible
53. Prion-inducing domain 2-114 of yeast sup35 protein transforms in vitro into amyloid-like filaments
54. Structural characterization of Sccharomyces cerevisiae prion-like protein Ure2
55. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231)
56. Prion protein NMR structure and familial human spongiform encephalopathies
57. Solution structure of Syrian hamster prion protein rPrP(90-231)
58. NMR structure of the bovine prion protein
59. NMR structures of three single-residue variants of the human prion protein
60. Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases
61. NMR solution structure of human prion protein
62. Prion protein and species barriers in the transmissible spongiform encephalopathies
63. Molecular assessment of the transmissibilities of BSE and scrapie to human
64. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms
65. Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae
66. Stability, folding, dimerization and assembly properties of the yeast prion Ure2p
67. Equilibrium folding properties of the yeast prion protein determinant Ure2
68. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH
69. Reversible conversion of monomeric human prion protein between native and fibrillogenic conformations
70. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated β-sheet structure for amyloid
71. Review: History of the amyloid fibril
72. Protein misfolding, evolution and disease
73. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae
74. In vitro propagation of the prion-like state of yeast Sup35 protein
75. Evidence for the prion hypothesis: Induction of the yeast [PSI+] factor by in vitro-converted Sup35 protein
76. Aggregation and fibrillization of the recombinant human prion protein huPrP
77. On the Mechanism of α-helix to β-sheet transition in the recombinant prion protein
78. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding
79. Regional mapping of prion proteins in brain
80. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast
81. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor
82. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells
83. Prion protein interconversions and the transmissible spongiform encephalopathies
84. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae
85. Non-genetic propagation of strain-specific properties of scrapie prion protein
86. Conformational diversity in a yeast prion dictates its seeding specificity
87. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier
88. Evolutionary conservation of prion-forming abilities of the yeast Sup35 protein
89. Prion properties of the Sup35 protein of yeast Pichia methanolica
90. Prion protein selectively binds copper(II) ions
91. Copper binding to the prion protein: Structural implications of four identical cooperative binding sites
92. Strain-specific prion-protein conformation determined by metal ions
93. Xafs study of the high-affinity copper-binding site of human prp(91-231) and its low-resolution structure in solution
94. 2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy
95. Crystal structures of the yeast prion Ure2p functional region in complex with glutathione and related compounds
96. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae
97. Normal host prion protein necessary for scrapie-induced neurotoxicity
98. Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system
99. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231)
100. Yeast prions and their prion-forming domain
101. The yeast prion [URE3] can be greatly induced by a functional mutated URE2 allele
102. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]
103. Structure and replication of yeast prions
104. De novo generation of a PrPSc-like conformation in living cells
105. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog
106. Mad cows meet psi-chotic yeast: The expansion of the prion hypothesis
107. Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads?
108. Mimicking dominant negative inhibition of prion replication through structure-based drug design
109. Crystal structure of the human prion protein reveals a mechanism for oligomerization